Sectra platform to handle NHS pathology cases for Diagnexia

SciBase has secured its first positive US medical policy from a major Blue Cross Blue Shield organization: Highmark will cover the company's Nevisense skin lesion assessment for patients being evaluated for possible melanoma.

Swedish medtech company NanoEcho has been declared bankrupt after failing to find a solution to its strained financial situation.

Stockholm-based healthtech company Encare has signed an agreement with the National Cancer Institute of Thailand (NCI Thailand) to support the implementation of Enhanced Recovery After Surgery (ERAS) in colorectal surgery. The Bangkok institute, which operates under Thailand’s Ministry of Public Health, is Encare’s first hospital partner in the country.

Bergen-based Lifecare has manufactured its first functional continuous glucose monitoring (CGM) implants through its own operations, rather than through an external contract manufacturer. The company calls it an important step toward controlled manufacturing of its implantable sensor technology.

FluoGuide has entered a collaboration with medical technology company Leica Microsystems to advance precision surgery for brain tumors by combining its lead product, FG001, with Leica's surgical microscope systems.

Södertälje-based Anocca has dosed the first patient in Sweden with its TCR-T cell therapy, which targets KRAS G12V mutations in pancreatic cancer. Sweden is the third European country where a patient has received the therapy.

Umeå-based biotech Omnio has raised EUR 2.9 million in an oversubscribed round from existing investors and shareholders. The funding will move the company's plasminogen-based therapy for hard-to-heal chronic wounds closer to clinical trials, with patient studies planned for 2027.